Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
40 hedge funds and large institutions have $96.7M invested in Marrone Bio Innovations, Inc. in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 9
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
8% more funds holding
Funds holding: 37 → 40 (+3)
7% more capital invested
Capital invested by funds: $90.5M → $96.7M (+$6.28M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$2.01M |
| 2 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$1.57M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$926K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$646K |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$471K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$3.73M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$776K |
| 3 |
Primecap Management
Pasadena,
California
|
-$583K |
| 4 |
Morgan Stanley
New York
|
-$388K |
| 5 |
Jane Street
New York
|
-$249K |
MBII Hedge Fund Activity: Q4 2013 in Review
40 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q4 2013, worth a combined $96.7M — up 6.9% from $90.5M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new MBII positions and 5 closed out — a net gain of 3 holders — while 18 added to existing stakes and 9 trimmed.
The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $2.01M. The largest seller was Massachusetts Financial Services, cutting an estimated $3.73M.
- 40 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q4 2013, up from 37 in Q3 2013.
- Funds reported $96.7M of Marrone Bio Innovations, Inc. stock for Q4 2013, up 6.9% quarter-over-quarter.
- 8 funds opened new Marrone Bio Innovations, Inc. positions in Q4 2013 and 5 closed out, a net change of +3 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q4 2013 was Gilder Gagnon Howe & Co, an estimated $2.01M added.
- The largest Marrone Bio Innovations, Inc. seller in Q4 2013 was Massachusetts Financial Services, an estimated $3.73M sold.
Based on aggregated 13F filings for Q4 2013.